Literature DB >> 16524738

Three acetylated flavonol glycosides from Forsteronia refracta that specifically inhibit p90 RSK.

Ya-Ming Xu1, Jeffrey A Smith, Deborah A Lannigan, Sidney M Hecht.   

Abstract

A survey of plant extracts for the presence of p90 ribosomal S6 kinase (RSK) inhibitors resulted in the isolation of three acetylated flavonol glycosides. Kaempferol 3-O-(2'',4''-O-diacetyl-alpha-l-rhamnopyranoside) (1), kaempferol 3-O-(3'',4''-O-diacetyl-alpha-l-rhamnopyranoside) (2), and kaempferol-3-O-(4''-O-acetyl-alpha-l-rhamnopyranoside) (3) were isolated from Forsteronia refracta as the first RSK inhibitors. Of these, compound 2 was found to be the best inhibitor with an IC(50) value of 89 nM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16524738     DOI: 10.1016/j.bmc.2006.01.066

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  De novo asymmetric syntheses of SL0101 and its analogues via a palladium-catalyzed glycosylation.

Authors:  Mingde Shan; George A O'Doherty
Journal:  Org Lett       Date:  2006-10-26       Impact factor: 6.005

2.  In vitro activity of dietary flavonol congeners against human cancer cell lines.

Authors:  Chrisiida Tsimplouli; Costas Demetzos; Margarita Hadzopoulou-Cladaras; Panayotis Pantazis; Konstantinos Dimas
Journal:  Eur J Nutr       Date:  2011-05-20       Impact factor: 5.614

3.  Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).

Authors:  Kristen M Reipas; Jennifer H Law; Nicole Couto; Sumaiya Islam; Yvonne Li; Huifang Li; Artem Cherkasov; Karen Jung; Amarpal S Cheema; Steven J M Jones; John A Hassell; Sandra E Dunn
Journal:  Oncotarget       Date:  2013-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.